{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:27:39Z","timestamp":1792301259077,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.gofs.2022.03.002","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T12:05:32Z","timestamp":1647000332000},"page":"462-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparaison de la dydrogest\u00e9rone avec une progest\u00e9rone micronis\u00e9e vaginale dans le transfert d\u2019embryon frais en FIV\/ICSI"],"prefix":"10.1016","volume":"50","author":[{"given":"M.","family":"Cessot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Salle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Labrune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Benchaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fraison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2022.03.002_bib0240","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009154.pub3","article-title":"Luteal phase support for assisted reproduction cycles","author":"van der Linden","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2022.03.002_bib0245","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/humupd\/dmm021","article-title":"An update of luteal phase support in stimulated IVF cycles","volume":"13","author":"Fatemi","year":"2007","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.gofs.2022.03.002_bib0250","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-0035-1545363","article-title":"Luteal phase support in in vitro fertilization","volume":"33","author":"Yanushpolsky","year":"2015","journal-title":"Seminars in Reproductive Medicine"},{"key":"10.1016\/j.gofs.2022.03.002_bib0255","first-page":"786","article-title":"Administration effects of single-dose GnRH agonist for luteal support in females undertaking IVF\/ICSI cycles: a meta-analysis of randomized controlled trials","volume":"19","author":"Song","year":"2020","journal-title":"Exp Ther Med"},{"issue":"Suppl 1","key":"10.1016\/j.gofs.2022.03.002_bib0260","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1472-6483(14)50063-6","article-title":"Examining the evidence: progesterone supplementation during fresh and frozen embryo transfer","volume":"29","author":"Shapiro","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.gofs.2022.03.002_bib0265","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.rbmo.2012.04.005","article-title":"Progesterone support in IVF: is evidence-based medicine translated to clinical practice\u00a0?. A worldwide web-based survey","volume":"25","author":"Vaisbuch","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.gofs.2022.03.002_bib0270","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1477-7827-10-107","article-title":"The optimal duration of progesterone supplementation in pregnant women after IVF\/ICSI: a meta-analysis","volume":"10","author":"Liu","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.gofs.2022.03.002_bib0275","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0378-5122(93)90064-O","article-title":"Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone","volume":"16","author":"Nahoul","year":"1993","journal-title":"Maturitas"},{"key":"10.1016\/j.gofs.2022.03.002_bib0280","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/13697137.2018.1450856","article-title":"Vaginal progesterone and the vaginal first-pass effect","volume":"21","author":"Warren","year":"2018","journal-title":"Climacteric"},{"key":"10.1016\/j.gofs.2022.03.002_bib0285","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/humrep\/14.3.606","article-title":"Pharmacokinetics of natural progesterone administered in the form of a vaginal tablet","volume":"14","author":"Levy","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1016\/j.gofs.2022.03.002_bib0290","article-title":"Luteal phase support in ART: an update","author":"Ghanem","year":"2012","journal-title":"Enhancing Success of Assisted Reproduction"},{"key":"10.1016\/j.gofs.2022.03.002_bib0295","doi-asserted-by":"crossref","first-page":"e685281","DOI":"10.1155\/2015\/685281","article-title":"Sexual absorption of vaginal progesterone: a randomized control trial","volume":"2015","author":"Merriam","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.gofs.2022.03.002_bib0300","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/humupd\/6.2.139","article-title":"Comparison between different routes of progesterone administration as luteal phase support in infertility treatments","volume":"6","author":"Tavaniotou","year":"2000","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.gofs.2022.03.002_bib0305","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - DUPHASTON 10mg, comprim\u00e9 pellicul\u00e9 - Base de donn\u00e9es publique des m\u00e9dicaments n.d. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=64866204&typedoc=R.(accessed January 4, 2022)."},{"key":"10.1016\/j.gofs.2022.03.002_bib0310","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13048-015-0205-8","article-title":"Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?","volume":"8","author":"Palomba","year":"2015","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.gofs.2022.03.002_bib0315","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.fertnstert.2016.10.031","article-title":"Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials","volume":"107","author":"Saccone","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2022.03.002_bib0320","doi-asserted-by":"crossref","first-page":"e0220450","DOI":"10.1371\/journal.pone.0220450","article-title":"Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?","volume":"14","author":"Netter","year":"2019","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.gofs.2022.03.002_bib0325","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.gofs.2022.03.002_bib0330","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/09513590.2015.1121982","article-title":"Dydrogesterone use in early pregnancy","volume":"32","author":"Mirza","year":"2016","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.gofs.2022.03.002_bib0335","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.earlhumdev.2008.12.016","article-title":"Dydrogesterone use during pregnancy: overview of birth defects reported since 1977","volume":"85","author":"Queisser-Luft","year":"2009","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.gofs.2022.03.002_bib0340","unstructured":"PubChem. Dydrogesterone n.d. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9051.(accessed April 21, 2020)."},{"key":"10.1016\/j.gofs.2022.03.002_bib0345","first-page":"433","article-title":"Comparison of oral dydrogesterone with vaginal progesteronefor luteal support in IUI cycles: a randomized clinical trial","volume":"13","author":"Khosravi","year":"2015","journal-title":"Iran J Reprod Med"},{"key":"10.1016\/j.gofs.2022.03.002_bib0350","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/09513590.2019.1655728","article-title":"Comparison of oral dydrogesterone and vaginal micronized progesterone for luteal phase support in intrauterine insemination","volume":"36","author":"Ta\u015f","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.gofs.2022.03.002_bib0355","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001703-199906000-00013","article-title":"Culture and transfer of human blastocysts","volume":"11","author":"Gardner","year":"1999","journal-title":"Curr Opin Obstetri Gynecol"},{"key":"10.1016\/j.gofs.2022.03.002_bib0360","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13048-016-0297-9","article-title":"Does the transfer of a poor quality embryo together with a good quality embryo affect the In Vitro Fertilization (IVF) outcome?","volume":"10","author":"Wintner","year":"2017","journal-title":"J Ovar Res"},{"key":"10.1016\/j.gofs.2022.03.002_bib0365","series-title":"WHO laboratory manual for the examination and processing of human semen. 5th ed","year":"2010"},{"key":"10.1016\/j.gofs.2022.03.002_bib0370","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.gofs.2022.03.002_bib0375","unstructured":"PCOS_Evidence-Based-Guidelines_20181009.pdf n.d."},{"key":"10.1016\/j.gofs.2022.03.002_bib0380","first-page":"15","article-title":"Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: a systematic review and individual participant data meta-analysis","author":"Griesinger","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.gofs.2022.03.002_bib0385","first-page":"148","article-title":"Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis","volume":"22","author":"Barbosa","year":"2018","journal-title":"JBRA Assist Reprod"},{"key":"10.1016\/j.gofs.2022.03.002_bib0390","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/humrep\/dex023","article-title":"A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization","volume":"32","author":"Tournaye","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.gofs.2022.03.002_bib0395","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jsbmb.2005.08.012","article-title":"Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study","volume":"97","author":"Chakravarty","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.gofs.2022.03.002_bib0400","first-page":"913","article-title":"Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): a randomized clinical trial","volume":"11","author":"Salehpour","year":"2013","journal-title":"Iran J Reprod Med"},{"key":"10.1016\/j.gofs.2022.03.002_bib0405","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/09513590.2015.1110136","article-title":"A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles","volume":"32","author":"Saharkhiz","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.gofs.2022.03.002_bib0410","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/humrep\/del520","article-title":"Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept","volume":"22","author":"Fatemi","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.gofs.2022.03.002_bib0415","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.fertnstert.2019.04.021","article-title":"Evaluation of progestogen supplementation for luteal phase support in fresh in\u00a0vitro fertilization cycles","volume":"112","author":"Mohammed","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2022.03.002_bib0420","first-page":"348","article-title":"Retrospective cohort studies: advantages and disadvantages","author":"Sedgwick","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2022.03.002_bib0425","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s11517-015-1299-2","article-title":"Estimating the chance of success in IVF treatment using a ranking algorithm","volume":"53","author":"G\u00fcvenir","year":"2015","journal-title":"Med Biol Eng Comput"},{"key":"10.1016\/j.gofs.2022.03.002_bib0430","first-page":"34","article-title":"Cumulative live-birth rates by maternal age after one or multiple in vitro fertilization cycles: an institutional experience","volume":"14","author":"Khalife","year":"2020","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.gofs.2022.03.002_bib0435","unstructured":"De Croo I, Colman R, De Sutter P, Tilleman K. Blastocyst transfer for all? Higher cumulative live birth chance in a blastocyst-stage transfer policy compared to a cleavage-stage transfer policy. Facts Views Vis Obgyn n.d.;11:169-76."},{"key":"10.1016\/j.gofs.2022.03.002_bib0440","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3109\/09513590.2012.702875","article-title":"A systematic review of dydrogesterone for the treatment of threatened miscarriage","volume":"28","author":"Carp","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.gofs.2022.03.002_bib0445","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1007\/s10815-020-01878-4","article-title":"Controlled ovarian stimulation and progesterone supplementation affect vaginal and endometrial microbiota in IVF cycles: a pilot study","volume":"37","author":"Carosso","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.gofs.2022.03.002_bib0450","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.rbmo.2017.04.005","article-title":"What fertility specialists should know about the vaginal microbiome: a review","volume":"35","author":"Garc\u00eda-Velasco","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.gofs.2022.03.002_bib0455","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/humrep\/17.2.337","article-title":"Bacterial colonization of the uterine cervix and success rate in assisted reproduction: results of a prospective survey","volume":"17","author":"Salim","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.gofs.2022.03.002_bib0460","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003414.pub3","article-title":"Cycle regimens for frozen-thawed embryo transfer","author":"Ghobara","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.gofs.2022.03.002_bib0465","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.apjr.2016.10.002","article-title":"Oral dydrogesterone for luteal support in frozen-thawed embryo transfer artificial cycles: a pilot randomized controlled trial","volume":"5","author":"Rashidi","year":"2016","journal-title":"Asian Pacific J Reprod"},{"key":"10.1016\/j.gofs.2022.03.002_bib0235","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00404-016-4217-4","article-title":"Comparison of four protocols for luteal phase support in frozen-thawed Embryo transfer cycles: a randomized clinical trial","volume":"295","author":"Zarei","year":"2017","journal-title":"Arch Gynecol Obstet"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718922001295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718922001295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:42:18Z","timestamp":1762854138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718922001295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2468718922001295"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2022.03.002","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparaison de la dydrogest\u00e9rone avec une progest\u00e9rone micronis\u00e9e vaginale dans le transfert d\u2019embryon frais en FIV\/ICSI","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2022.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}